BCYC
Bicycle Therapeutics·NASDAQ
--
--(--)
--
--(--)
BCYC fundamentals
Bicycle Therapeutics (BCYC) released its earnings on Aug 8, 2025: revenue was 2.92M (YoY -68.81%), missed estimates; EPS was -1.14 (YoY -48.05%), missed estimates.
Revenue / YoY
2.92M
-68.81%
EPS / YoY
-1.14
-48.05%
Report date
Aug 8, 2025
EPS
Actual | -0.63 | -0.67 | -0.52 | -0.83 | -0.73 | -0.74 | -0.59 | -0.63 | -0.93 | -0.9 | -0.96 | -1.01 | -1.3 | -1.41 | -1.26 | -1.16 | -0.62 | -0.77 | -0.74 | -0.75 | -0.88 | -1.14 | |||
Forecast | -0.3675 | -0.4757 | -0.5175 | -0.4725 | -0.7067 | -0.7111 | -0.611 | -0.6155 | -0.68 | -0.8486 | -0.9 | -1.0589 | -1.0779 | -1.1998 | -1.2008 | -1.2334 | -1.251 | -1.1077 | -0.7966 | -0.8568 | -0.8417 | -0.9462 | |||
Surprise | 0.00% | 0.00% | 0.00% | -71.43% | -40.85% | -0.48% | -75.66% | -3.30% | -4.06% | +3.44% | -2.36% | -36.76% | -6.06% | -6.67% | +4.62% | -20.60% | -17.52% | -4.93% | +5.95% | +50.44% | +30.49% | +7.11% | +12.46% | -4.55% | -20.48% |
Revenue
Actual | -- | -- | -- | 1.13M | 1.57M | 3.82M | 3.85M | 1.81M | 1.78M | 4.33M | 3.77M | 3.86M | 4.38M | 3.04M | 3.19M | 4.90M | 11.40M | 5.35M | 5.33M | 19.53M | 9.36M | 2.68M | 3.71M | 9.98M | 2.92M |
Forecast | -- | -- | -- | 3.50M | 2.36M | 2.73M | 3.66M | 1.81M | 2.31M | 5.75M | 5.52M | 4.46M | 3.69M | 5.70M | 3.55M | 3.88M | 5.78M | 12.94M | 6.98M | 6.06M | 6.13M | 6.82M | 5.42M | 8.24M | 9.43M |
Surprise | 0.00% | 0.00% | 0.00% | -67.79% | -33.48% | +40.21% | +5.26% | -0.28% | -22.64% | -24.63% | -31.73% | -13.54% | +18.70% | -46.70% | -10.35% | +26.29% | +97.34% | -58.65% | -23.66% | +222.11% | +52.72% | -60.76% | -31.60% | +21.11% | -69.03% |
Earnings Call
You can ask Aime
What were the key takeaways from Bicycle Therapeutics’s earnings call?What does Bicycle Therapeutics do and what are its main business segments?What guidance did Bicycle Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Bicycle Therapeutics year over year?Did Bicycle Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Bicycle Therapeutics's revenue and profit?What were the key takeaways from Bicycle Therapeutics's earnings call?What is the market's earnings forecast for Bicycle Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
